Greenberg Traurig Maher (GTM) and Skadden Arps Meagher & Flom have taken lead roles on AstraZeneca’s $1.8bn (£1.1bn) sale of its Swedish dental subsidiary Astra Tech to Dentsply International.

GTM took the lead role for AstraZeneca on the sale, which came after a competitive auction process run by JP Morgan. London co-managing shareholders Paul Maher (pictured) and Fiona Adams took the lead roles for the firm.